RxDoctor Payments Data

Rhonda Clark, NP

Nurse Practitioner · Collinsville, VANPI 1154379451

Payments from drug & device makers

$1,038in general payments, 2019–2025

Across 54 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$158
  • AbbVie$154
  • Novo Nordisk$147
  • Lilly USA, LLC$120
  • Amgen$90
  • Inspire Medical Systems, Inc.$80
  • plus $289 from 9 others

What the payments were for

  • Food & beverage$1,038100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,038 in reported general payments places this provider in the 80th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$60,618
Medicare patients
173
Services billed
827

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide109$137,686
TrulicityDulaglutide81$114,476
EliquisApixaban85$91,869
JanuviaSitagliptin Phosphate54$72,935
Tresiba Flextouch U-100Insulin Degludec67$51,007
LinzessLinaclotide56$49,386
JardianceEmpagliflozin38$47,018
FarxigaDapagliflozin Propanediol33$38,298
MounjaroTirzepatide27$35,295
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog31$34,831
XareltoRivaroxaban22$34,389
EntrestoSacubitril/Valsartan22$31,925
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$22,338
Combivent RespimatIpratropium/Albuterol Sulfate32$20,701
Nurtec OdtRimegepant Sulfate16$15,903

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$120$149,772108 claims
Novo NordiskOzempic$147$137,686109 claims
PfizerEliquis, Nurtec Odt$53$107,772101 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$158$56,17577 claims
AbbVieLinzess$154$49,38656 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$13$41,83457 claims
Johnson & JohnsonXarelto$39$34,38922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Collinsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →